Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

Based on available data, most multiple myeloma patients have residual myeloma cells in their autologous hematopoietic progenitor cells (HPC) grafts during collection for autologous stemcell transplant. However, available literature is based on older induction regimens, e.g., adriamycin and dexametha...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Bone Marrow Transplant
Main Authors: Tageja, Nishant, Korde, Neha, Kazandjian, Dickran, Manasanch, Elisabet, Bhutani, Manisha, Kwok, Mary, Mailankody, Sham, Yuan, Constance, Stetler-Stevenson, Maryalice, Leitman, Susan F., Sportes, Claude, Landgren, Ola
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740327/
https://ncbi.nlm.nih.gov/pubmed/29728700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0170-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki